It’s a weak ACE2 binder per in silico studies but is anticipated to bind to several sites on the virus, including S1 RBD and S2 spike subunits and protease / replicase. As a small molecule it’s abrogating smaller sites than peps. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996102/ … https://iv.iiarjournals.org/content/34/5/3023.short …
-
-
-
thanks!
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
